| Status: In progress | |
As off-label monotherapy for patients with oesophageal and gastric cancer with high microsatellite instability or mismatch repair deficiency, used in palliative care setting as first line treatment. |
|
Medicine details |
|
| Medicine name | nivolumab (Opdivo®) |
| Formulation | concentrate for solution for infusion |
| Reference number | OW28 |
| Indication | As above |
| Company | Bristol Myers Squibb |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | One Wales |
| Status | In progress |
| AWMSG meeting date | 09/07/2024 |
| Date of issue | TBC |